REVIEW  RESPIRATORY SYNCYTIAL VIRUS IN INFANTS 

Minerva Pediatrica 2018 December;70(6):600-11

DOI: 10.23736/S0026-4946.18.05334-3

Copyright © 2018 EDIZIONI MINERVA MEDICA

language: English

Bronchiolitis clinics and medical treatment

Fabio MIDULLA ✉, Laura PETRARCA, Antonella FRASSANITO, Greta DI MATTIA, Anna Maria ZICARI, Raffaella NENNA

Department of Pediatrics, Sapienza University, Rome, Italy

Bronchiolitis is the most common acute lower respiratory tract infection in infants and the first cause of hospitalization in this age group. Despite it has been studied for over 70 years, its management remains controversial and nowadays the treatment is only supportive. Pediatricians should be well acquainted with the clinical course of the disease. In particular, they should know that the severity of respiratory symptoms peaks between days 3-7 of the disease and dehydration is a key sign to consider for the management. In this review, we will discuss the most controversial points in the management of bronchiolitis according to six evidence-based guidelines, six clinical practice guidelines and five consensus-based reviews.

KEY WORDS: Bronchiolitis - Guideline - Therapeutics - Disease management